Minimed Group (MMED) closed at $16.71 on November 6, 2026, down 8.0% from the previous close, on volume of 6,721,335 shares (30-day average 13,822,190).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 8, 2026 | Conversion/Reversal | 16-Oct-2630 C : 30 P +1,000,000 Stock | 94,600 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
MiniMed to Participate in Upcoming Investor Conferences
PRNewswire (Thu, 5-Nov 8:00 AM ET)
MiniMed to Announce Its Fiscal Year 2027 Second Quarter Financial Results
PRNewswire (Wed, 4-Nov 4:15 PM ET)
MiniMed Appoints Dr. David Segal as Chief Medical Officer
PRNewswire (Tue, 3-Nov 9:20 AM ET)
William Blair refreshes stock Conviction List with 5 additions, 3 removals
Seeking Alpha News (Mon, 2-Nov 8:56 AM ET)
Medtronic Completes Separation of MiniMed Group, Inc.
PRNewswire (Thu, 15-Oct 10:01 AM ET)
MiniMed Completes Separation from Medtronic
PRNewswire (Thu, 15-Oct 10:01 AM ET)
Market Chameleon (Wed, 14-Oct 7:39 AM ET)
Medtronic Announces Final Results of MiniMed Group, Inc. Exchange Offer
PRNewswire (Wed, 14-Oct 8:00 AM ET)
MiniMed (MMED) Exchange Offer Was Oversubscribed as Medtronic Moves to Exit Its Remaining Stake
Market Chameleon (Mon, 12-Oct 5:38 AM ET)
Medtronic Announces Preliminary Results of MiniMed Group, Inc. Exchange Offer
PRNewswire (Mon, 12-Oct 8:45 AM ET)
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.
Minimed Group trades on the NASDAQ stock market under the symbol MMED.
As of November 6, 2026, MMED stock price declined to $16.71 with 6,721,335 million shares trading.
MMED has a beta of 0.70, meaning it tends to be less sensitive to market movements. MMED has a correlation of 0.03 to the broad based SPY ETF.
MMED has a market cap of $4.70 billion. This is considered a Mid Cap stock.
Last quarter Minimed Group reported $843 million in Revenue and $.00 earnings per share. This beat revenue expectation by $15 million and missed earnings estimates by -$.09.
The top ETF exchange traded funds that MMED belongs to (by Net Assets): IWM, IWN, SCHA, FESM, FPX.
MMED support price is $17.44 and resistance is $18.87 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MMED shares will trade within this expected range on the day.
